Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Celebrex, Kaletra, Zestril, Zestoretic
Link ID 3778
Title FDA Safety Changes: Celebrex, Kaletra, Zestril, Zestoretic
Url http://www.medscape.com/viewarticle/571029?src=rss
Description The FDA has approved revisions to the safety labeling for celecoxib capsules, lopinavir/ritonavir tablets and oral solution, lisinopril tablets, and lisinopril/hydrochlorothiazide tablets. Medscape Medical News
Category Articles > Allergy and Clinical Immunology
Keywords
Date Mar 6, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. Low CD4-Cell Counts - Not Just About OI Risk
  Will maintaining high CD4-cell counts reduce the risk for AIDS-defining conditions, and also for non-AIDS-defining disease?
AIDS Clinical Care
Category:   Articles > Allergy and Clinical Immunology


2. Four Cases of Disseminated Mycobacterium bovis Infection Following Intravesical BCG Instillation for
  A rare but severe complication of BCG immunotherapy is the development of disseminated BCG disease.
Southern Medical Journal
Category:   Articles > Allergy and Clinical Immunology


3. Time to Heal?
  Karen Donelan, ScD, Senior Scientist in Health Policy, Massachusetts General Hospital, Boston, discusses how much time it takes to be sick, screened, and healthy and about making the system better.
The Medscape Journal of Medicine
Category:   Articles > Allergy and Clinical Immunology


4. FDA Device Clearances: Airway Inflammation Measurement Device, Intraosseous Infusion System, Metatar
  The FDA has granted 510(k) clearance for an airway inflammation measurement device (Niox Mino), an intraosseous infusion system (Fast1), and a metatarsal resurfacing implant system (OsteoMed Metatarsal). Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


5. Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatmen
  Targeted immunomodulating monoclonal antibodies are believed to cause fewer infectious sequelae than standard cytotoxic therapies for hematologic malignancies. The specific infections related to these new cancer therapeutics are reviewed. Journal of the National Comprehensive Cancer Network
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS